As China prepares to beef up its weight loss medication market, the Danish firm that makes Ozempic and Wegovy may soon have its dominance threatened.Chinese drug manufacturers are working on creating at least 15 generic versions of the glucagon-like peptide-1 agonist drugs as Ozempic maker Novo Nordisk makes money hand over fist in the region., Novo saw the diabetes drug Ozempic sales in the country nearly double over the last few years, topping out at nearly $700 million.
I understand and agree that registration on or use of this site constitutes agreement to its User Agreement and Privacy Policy
United Kingdom United Kingdom Latest News, United Kingdom United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: CNBC - 🏆 12. / 72 Read more »